PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.31%
Negative revenue growth while QCOM stands at 11.50%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-58.24%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
250.00%
EBIT growth above 1.5x QCOM's 98.92%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
250.00%
Operating income growth above 1.5x QCOM's 98.92%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
147.06%
Net income growth of 147.06% while QCOM is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
148.23%
EPS growth above 1.5x QCOM's 48.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
148.23%
Diluted EPS growth above 1.5x QCOM's 48.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-29.30%
Share reduction while QCOM is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-29.30%
Reduced diluted shares while QCOM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
53.23%
Dividend growth of 53.23% while QCOM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-97.71%
Negative OCF growth while QCOM is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-130.90%
Negative FCF growth while QCOM is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
85.05%
10Y revenue/share CAGR at 50-75% of QCOM's 117.24%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
69.30%
5Y revenue/share CAGR at 50-75% of QCOM's 117.24%. Martin Whitman would worry about a lagging mid-term growth trajectory.
41.60%
3Y revenue/share CAGR under 50% of QCOM's 117.24%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
484.92%
10Y net income/share CAGR of 484.92% while QCOM is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-31.93%
Negative 5Y net income/share CAGR while QCOM is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-36.89%
Negative 3Y CAGR while QCOM is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
158.20%
Dividend/share CAGR of 158.20% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
139.08%
3Y dividend/share CAGR of 139.08% while QCOM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
0.22%
AR growth of 0.22% while QCOM is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
1.84%
Inventory shrinking or stable vs. QCOM's 20.34%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-6.19%
Negative asset growth while QCOM invests at 159.13%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
37.76%
Under 50% of QCOM's 2534.62%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-11.77%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-9.17%
We cut SG&A while QCOM invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.